Literature DB >> 9309516

Aromatic L-amino acid decarboxylase deficiency: clinical features, diagnosis, and treatment of a second family.

A Maller1, K Hyland, S Milstien, I Biaggioni, I J Butler.   

Abstract

Aromatic L-amino acid decarboxylase deficiency is an inborn error of metabolism that leads to combined serotonin and catecholamine deficiency, first described by Hyland et al in 1990. The clinical features, biochemical findings, and treatment of the second family with this condition are reported. Our male patient presented with developmental delay, extreme hypotonia, oculogyric crises, and irritability. The diagnosis of this inborn error of biogenic amine metabolism was accomplished by determining low concentrations of homovanillic, 5-hydroxyindoleacetic acid, and 3-methoxy-4-hydroxyphenyl-ethyleneglycol in cerebrospinal fluid with normal biopterin metabolism and increased L-dopa, in plasma, cerebrospinal fluid, and urine. Greatly reduced activity of aromatic L-amino acid decarboxylase in plasma confirmed this diagnosis. Combined treatment with pyridoxine, tranylcypromine, and bromocriptine produced some clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9309516     DOI: 10.1177/088307389701200602

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  13 in total

Review 1.  Neurochemistry and defects of biogenic amine neurotransmitter metabolism.

Authors:  K Hyland
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  Pathobiochemical implications of hyperdopaminuria in patients with aromatic L-amino acid decarboxylase deficiency.

Authors:  N G Abeling; C Bräutigam; G F Hoffmann; P G Barth; R A Wevers; J Jaeken; A Fiumara; A Knust; A H van Gennip
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

Review 3.  Monoamine neurotransmitter disorders--clinical advances and future perspectives.

Authors:  Joanne Ng; Apostolos Papandreou; Simon J Heales; Manju A Kurian
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

4.  Treatment of congenital neurotransmitter deficiencies by intracerebral ventricular injection of an adeno-associated virus serotype 9 vector.

Authors:  Ni-Chung Lee; Yin-Hsiu Chien; Min-Hsiu Hu; Wen-Shin Liu; Pin-Wen Chen; Wei-Hua Wang; Kai-Yuan Tzen; Barry J Byrne; Wuh-Liang Hwu
Journal:  Hum Gene Ther       Date:  2014-01-07       Impact factor: 5.695

5.  Aromatic L-amino acid decarboxylase deficiency: clinical features, drug therapy and follow-up.

Authors:  C Manegold; G F Hoffmann; I Degen; H Ikonomidou; A Knust; M W Laass; M Pritsch; E Wilichowski; F Hörster
Journal:  J Inherit Metab Dis       Date:  2009-01-28       Impact factor: 4.982

6.  Chronic Diarrhea in L-Amino Acid Decarboxylase (AADC) Deficiency: A Prominent Clinical Finding Among a Series of Ten French Patients.

Authors:  M A Spitz; M A Nguyen; S Roche; B Heron; M Milh; P de Lonlay; L Lion-François; H Testard; S Napuri; M Barth; S Fournier-Favre; L Christa; C Vianey-Saban; C Corne; A Roubertie
Journal:  JIMD Rep       Date:  2016-05-05

Review 7.  Pediatric neurotransmitter diseases.

Authors:  Phillip L Pearl; Denise D Wallis; K Michael Gibson
Journal:  Curr Neurol Neurosci Rep       Date:  2004-03       Impact factor: 5.081

8.  Clinical Profile and Outcome of Indian Children with Aromatic L-Amino Acid Decarboxylase Deficiency: A primary CSF Neurotransmitter Disorder Mimicking as Dyskinetic Cerebral Palsy.

Authors:  Vykuntaraju K Gowda; Hemadri Vegda; Balamurugan B Nagarajan; Sanjay K Shivappa
Journal:  J Pediatr Genet       Date:  2020-07-27

9.  Aromatic amino Acid decarboxylase deficiency not responding to pyridoxine and bromocriptine therapy: case report and review of response to treatment.

Authors:  Majid Alfadhel; Rana Kattan
Journal:  J Cent Nerv Syst Dis       Date:  2014-01-07

10.  Aromatic L-Amino acid decarboxylase deficiency: A new case from Turkey with a novel mutation.

Authors:  Kıvılcım Gücüyener; Ciğdem Seher Kasapkara; Leyla Tümer; Marcel M Verbeek
Journal:  Ann Indian Acad Neurol       Date:  2014-04       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.